Yüklüyor......
An engineered receptor-binding domain improves the immunogenicity of multivalent SARS-CoV-2 vaccines
The SARS-coronavirus 2 (SARS-CoV-2) spike (S) protein mediates viral entry into cells expressing the angiotensin-converting enzyme 2 (ACE2). The S protein engages ACE2 through its receptor-binding domain (RBD), an independently folded 197-amino acid fragment of the 1273-amino acid S-protein protomer...
Kaydedildi:
| Yayımlandı: | bioRxiv |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Cold Spring Harbor Laboratory
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7685318/ https://ncbi.nlm.nih.gov/pubmed/33236008 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.11.18.388934 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|